Literature DB >> 7936853

The increased rate of stimulant treatment for hyperactive/inattentive students in secondary schools.

D J Safer1, J M Krager.   

Abstract

OBJECTIVE: To describe trends in medication use for hyperactive/inattentive (HA/I) secondary school students from 1975 through 1993 and to present differences in the treatment of HA/I relative to school grade.
DESIGN: A comprehensive survey of the HA/I treatment of public elementary and secondary school students has been conducted biennially by school nurses in Baltimore County, MD since 1975.
RESULTS: Although only 11% of all public school students on medication for HA/I were in secondary schools in 1975, the proportion gradually rose such that in the 1990s, 30% of all medicated students were attending secondary schools. Also in secondary schools, the gender ratio for students on medication for HA/I narrowed from a 1:12 female/male ratio in 1981 to a 1:6 female/male ratio in 1993.
CONCLUSIONS: Many more elementary school students are now remaining on stimulant medication for HA/I into their teens. Compared with a decade ago, relatively more girls are on stimulant treatment for HA/I during their secondary school years.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7936853

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  10 in total

1.  Methylphenidate role in Tourette syndrome prevalence.

Authors:  J G Millichap
Journal:  J R Soc Med       Date:  1999-03       Impact factor: 5.344

2.  Is attention deficit hyperactivity disorder increasing among girls in the US? Trends in diagnosis and the prescribing of stimulants.

Authors:  Linda M Robison; Tracy L Skaer; David A Sclar; Richard S Galin
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Methylphenidate: use in daily practice.

Authors:  Jacqueline G Hugtenburg; Judith E Griekspoor; Ingrid De Boer; Eibert R Heerdink; Yung Hwo Tso; Antoine C G Egberts
Journal:  Pharm World Sci       Date:  2005-06

4.  Psychotropic medication use among children in foster care: relationship to severe psychiatric disorders.

Authors:  B T Zima; R Bussing; G M Crecelius; A Kaufman; T R Belin
Journal:  Am J Public Health       Date:  1999-11       Impact factor: 9.308

Review 5.  The efficacy, safety, and practicality of treatments for adolescents with attention-deficit/hyperactivity disorder (ADHD).

Authors:  B H Smith; D A Waschbusch; M T Willoughby; S Evans
Journal:  Clin Child Fam Psychol Rev       Date:  2000-12

6.  The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools.

Authors:  G B LeFever; K V Dawson; A L Morrow
Journal:  Am J Public Health       Date:  1999-09       Impact factor: 9.308

7.  Prevalence of methylphenidate use among Israeli children: 1998-2004.

Authors:  Shlomo Vinker; Rina Vinker; Asher Elhayany
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

8.  A surveillance method for the early identification of idiosyncratic adverse drug reactions.

Authors:  Fatma A Etwel; Michael J Rieder; John R Bend; Gideon Koren
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 9.  Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement.

Authors:  James Swanson
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.

Authors:  Els van den Ban; Patrick C Souverein; Hanna Swaab; Herman van Engeland; Toine C G Egberts; Eibert R Heerdink
Journal:  Atten Defic Hyperact Disord       Date:  2010-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.